Online First Nr63

Psychiatr. Pol. ONLINE FIRST Nr 63 1–13

Published ahead of print 10 February 2017


Anna Mosiołek, Jacek Gierus, Tytus Koweszko,
Alina Borkowska, Marta Janus, Agata Szulc

Przesiewowa Skala Funkcji Poznawczych w Schizofrenii (CSSS). Część 1. Konstrukcja i struktura skali

The Cognitive Screening Scale for Schizophrenia (CSSS). Part 1. Design and structure of the scale

Introduction. This paper presents the construction of the CSSS – a short screening scale intended for diagnosis of cognitive deficits among people with schizophrenia.
Material and methods. 160 persons (124 with schizophrenia and 36 healthy controls)were tested using the initial version of the CSSS scale consisting of 11 subscales. Correlation analysis between the subscalesʼ results was carried out, as well as confirmatory factor analysis, internal consistency analysis of the scale, IRT (item response theory) analysis of the itemsʼ difficulty, and analysis of the scaleʼs accuracy as a classifier.
Results. One factor (overall cognitive efficiency) explains 37% of the variance of the subscalesʼ results. The scale has satisfactory internal consistency (Cronbachʼs alfa = 0.83). Subjects with schizophrenia achieved significantly lower scores than healthy subjects. The area under the ROC curve (AUC) for discriminating between subjects with schizophrenia and healthy subjects was 0.83. Cut-off point of 16 raw points is 86% sensitive and has 70% specificity.
Conclusions. The form of the tool that has been achieved as a result of presented analyses suggests that this scale has a potential to fulfil the assumed goals, which will be tested during continuing validation studies.

ISSN 0033-2674 (PRINT)

ISSN 2391-5854 (ONLINE)

Inne strony PTP:
Other PTP websites:

Psychiatria Polska
Thomson Reuters Master List
Science Citation Index Expanded
Journal Citation Reports
(Impact Factor 0,884)

Medline/Index Medicus
MNiSW (15 pkt)
EMBASE/Excerpta Medica
Index Copernicus (18.59)
Erih Plus, Cochrane Library

Psychiatria Polska
is an open access journal

We recommend:
Pharmacological Reports

+48  518-330-994
kontakt z Biurem KRW PTP